+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Disruption of a putative ABC transporter in Plasmodium falciparum alters parasite growth and responses to antimalarial drugs



Disruption of a putative ABC transporter in Plasmodium falciparum alters parasite growth and responses to antimalarial drugs








Accession: 020874027

Download citation: RISBibTeXText


Related references

Disruption of a Plasmodium falciparum multidrug resistance-associated protein (PfMRP) alters its fitness and transport of antimalarial drugs and glutathione. Journal of Biological Chemistry 284(12): 7687-7696, 2009

Modulation of PF10_0355 (MSPDBL2) alters Plasmodium falciparum response to antimalarial drugs. Antimicrobial Agents and ChemoTherapy 57(7): 2937-2941, 2013

The crystal structure of Plasmodium falciparum glutamate dehydrogenase, a putative target for novel antimalarial drugs. Journal of Molecular Biology 349(3): 597-607, 2005

Influence of the asexual parasite biomass on in vitro susceptibility of Plasmodium falciparum to antimalarial drugs in Abidjan. African Journal Of Biotechnology: 8, 936-940. Ef, 2008

Plasmodium falciparum: effect of antimalarial drugs, malaria pigment (β-haematin) and Plasmodium falciparum lysate on monocyte GTP-cyclohydrolase 1 gene expression. Experimental Parasitology 129(3): 312-317, 2011

Ex vivo responses of Plasmodium falciparum clinical isolates to conventional and new antimalarial drugs in Niger. Antimicrobial Agents and ChemoTherapy 57(7): 3415-3419, 2013

Male and female Plasmodium falciparum mature gametocytes show different responses to antimalarial drugs. Antimicrobial Agents and ChemoTherapy 57(7): 3268-3274, 2013

Interaction between antimalarial drugs and the immune response to the malarial infection. The effect of antibodies alone or in combination with antimalarial drugs, upon the development in vitro of Plasmodium falciparum. Tropical Biomedicine 14(1/2): 11-17, 1997

Responses of Plasmodium falciparum infections to antimalarial drugs in north eastern Nigeria - Part 1: 1988-1995. Journal of Pharmacy and Bioresources 1(1): 51-60, 2004

Plasmodium falciparum: evaluation of lactate dehydrogenase in monitoring therapeutic responses to standard antimalarial drugs in Nigeria. Experimental Parasitology 87(3): 283-289, 1997

Effects of hydroxypyridinone iron chelators in combination with antimalarial drugs on the in vitro growth of Plasmodium falciparum. Southeast Asian Journal of Tropical Medicine and Public Health 32(1): 64-69, 2001

Licochalcone A, a new antimalarial agent, inhibits in vitro growth of the human malaria parasite Plasmodium falciparum and protects mice from P. yoelii infection. Antimicrobial Agents and ChemoTherapy 38(7): 1470-1475, 1994

Gametocytocidal activity and synergistic interactions of riboflavin with standard antimalarial drugs against growth of Plasmodium falciparum in vitro. Antimicrobial Agents and Chemotherapy 44(11): 3107-3111, 2000

Verapamil-Sensitive Transport of Quinacrine and Methylene Blue via the Plasmodium falciparum Chloroquine Resistance Transporter Reduces the Parasite's Susceptibility to these Tricyclic Drugs. Journal of Infectious Diseases 213(5): 800-810, 2016